Session 3: GDPR and Data Transparency Requirements
Merete Joergensen, MBA, MSc
Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark
How to ensure Data privacy and being Transparent at the same time gives rise to some considerations and concerns. What does this mean from a patient perspective, what are the considerations from industry trying to manoeuvre the requirements and what are the legal reality when working in this field.
David Peloquin, JD
Senior Advisor, MRCT Center; Associate, Health care Group
Ropes & Gray LLP, United States
Patient's perspectives on Data Privacy versus Data Transparency: Deborah Collyar
Patient Advocates In Research (PAIR), United States
GDPR and Data Transparency: An Industry Perspective’ : Anne Cutting
Director, Human Subject Research Governance
GSK, United Kingdom
Have an account?